Singaporean authorities do not believe there is sufficient evidence supporting the efficacy of “raw” cannabis, considering the plant and its derivatives to be a dangerous drug with few medical benefits ...
15% OFF on our latest reports
Use the code CBD15OFF to apply the discount on the following available reports:
·
Interest booming in online CBD sales: Germany market report
· CBD in the UK: consumer choices and behaviours under the spotlight
· EU states could deem CBD, other cannabinoids illegal in cosmetics
· Cannabis to be legalised? Mexico regulatory report
*Offer available until 31st of Marchport.
Start your FREE trial version
Sign up to access to our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
